Literature DB >> 14679205

Glycodelin A, not glycodelin S, is apoptotically active. Relevance of sialic acid modification.

Debaditya Mukhopadhyay1, Swathi SundarRaj, Anshula Alok, Anjali A Karande.   

Abstract

Glycodelin, previously known as PP14 (placental protein-14), is a kernel lipocalin secreted by the glandular epithelium of the endometrium upon progesterone stimulation and by the seminal vesicles. The isoform of the protein present in female reproductive tissue, glycodelin A (GdA), and the male counterpart, glycodelin S (GdS), have identical amino acid sequences, but strikingly different N-linked glycans. It is well documented in literature that GdA is an immunosuppressive protein, and we have shown that this activity is due to its ability to induce apoptosis in activated T cells. The precise role of GdS in seminal plasma is not known. In this study, we report that GdS is not apoptotically active. We observe that the apoptotic activity requires the presence of sialic acid residues on the complex glycans, as in the case of GdA; however, complex glycans of GdS are non-sialylated. We have expressed the wild-type protein in Pichia pastoris, which does not add sialic acid to the secreted proteins, and confirmed our observations that the protein is apoptotically inactive in the non-sialylated form. Our results indicate that differential glycosylation modulates the function of the different glycodelin isoforms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14679205     DOI: 10.1074/jbc.M306673200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  High throughput, cell type-specific analysis of key proteins in human endometrial biopsies of women from fertile and infertile couples.

Authors:  Richard E Leach; Philip Jessmon; Christos Coutifaris; Michael Kruger; Evan R Myers; Rouba Ali-Fehmi; Sandra A Carson; Richard S Legro; William D Schlaff; Bruce R Carr; Michael P Steinkampf; Susan Silva; Phyllis C Leppert; Linda Giudice; Michael P Diamond; D Randall Armant
Journal:  Hum Reprod       Date:  2012-01-02       Impact factor: 6.918

2.  Inhibition of effector function but not T cell activation and increase in FoxP3 expression in T cells differentiated in the presence of PP14.

Authors:  Zohar Ochanuna; Anat Geiger-Maor; Adi Dembinsky-Vaknin; Dimitrios Karussis; Mark L Tykocinski; Jacob Rachmilewitz
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

3.  Mapping the apoptosis inducing domain of an immunomodulatory protein: glycodelin A.

Authors:  Devasena Ponnalagu; Anjali A Karande
Journal:  Mol Cell Biochem       Date:  2013-02-08       Impact factor: 3.396

4.  Effects of differential glycosylation of glycodelins on lymphocyte survival.

Authors:  Cheuk-Lun Lee; Poh-Choo Pang; William S B Yeung; Bérangère Tissot; Maria Panico; Terence T H Lao; Ivan K Chu; Kai-Fai Lee; Man-Kin Chung; Kevin K W Lam; Riitta Koistinen; Hannu Koistinen; Markku Seppälä; Howard R Morris; Anne Dell; Philip C N Chiu
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

5.  Increased expression of glycodelin mRNA and protein in rat lungs during ovalbumin-induced allergic airway inflammation.

Authors:  Christiane Kunert-Keil; Udo Jeschke; Giles Simms; Michael Kasper
Journal:  Histochem Cell Biol       Date:  2008-11-12       Impact factor: 4.304

6.  Expression and analysis of the glycosylation properties of recombinant human erythropoietin expressed in Pichia pastoris.

Authors:  Ser Huy Teh; Mun Yik Fong; Zulqarnain Mohamed
Journal:  Genet Mol Biol       Date:  2011-07-01       Impact factor: 1.771

7.  Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study.

Authors:  Selda Uysal; Ahmet Zeki Isik; Serenat Eris; Seyran Yigit; Yakup Yalcin; Pelin Ozun Ozbay
Journal:  Obstet Gynecol Int       Date:  2015-02-28

Review 8.  The Roles of Glycodelin in Cancer Development and Progression.

Authors:  Juan Cui; Yanguo Liu; Xiuwen Wang
Journal:  Front Immunol       Date:  2017-11-29       Impact factor: 7.561

9.  Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer.

Authors:  Miriam Lenhard; Sabine Heublein; Christiane Kunert-Keil; Thomas Vrekoussis; Isabel Lomba; Nina Ditsch; Doris Mayr; Klaus Friese; Udo Jeschke
Journal:  BMC Cancer       Date:  2013-12-30       Impact factor: 4.430

10.  Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.

Authors:  Marc A Schneider; Thomas Muley; Nicolas C Kahn; Arne Warth; Michael Thomas; Felix J F Herth; Hendrik Dienemann; Michael Meister
Journal:  Oncotarget       Date:  2016-11-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.